Antihypertensive drugs

  title={Antihypertensive drugs},
  author={St{\'e}phane Laurent},
  journal={Pharmacological Research},
  • S. Laurent
  • Published 2017
  • Medicine, Biology
  • Pharmacological Research

Figures and Tables from this paper

Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response

Genotype screening of specific hepatic drug-metabolizing enzymes may contribute to optimize dose selection and to increase the rate of blood pressure control in patients treated with specific β-blockers, calcium channel blockers, and angiotensin receptor blockers.

Drug–drug interactions involving antipsychotics and antihypertensives

The current knowledge is sufficiently strong to guide clinicians in selecting safer drug combinations as summarized here to provide the clinician an insight into the pharmacokinetic and pharmacodynamic interactions between these drugs.

Selection of antihypertensive drugs from the perspective of clinical pharmacology

ACE inhibitors, diuretics, BAB, CCB and ARB have been first-line drugs in the arterial hypertension (AHT) treatment and direct vasodilators as hydralazine, labetalol, sodium nitroprusside remains magnesium sulfate.

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer

This review examines the preclinical and clinical evidence for utilizing antihypertensive agents in the treatment of cancer and some of these drugs have exhibited pharmacological properties useful for the Treatment of cancer, rendering them candidates for drug repurposing.

The immunomodulatory effects of antihypertensive therapy: A review.

Features of antihypertensive pharmacotherapy in patients with metabolic syndrome and diabetes mellitus

The authors argue in favour of the use of antihypertensive drug combinations in one dosage form as one of the effective ways to solve the problem of adherence to treatment in elderly patients and patients with concomitant metabolic disorders.

Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension

Significant efforts have been made in developing new classes of drugs that lower BP; with several of these emerging classes in phase III clinical trials, it is hoped that the discovery of these novel therapeutic avenues will aid in reducing the global burden of hypertension.

Pharmacogenomics of Hypertension Treatment

The results of numerous studies confirm that genotype-based antihypertension therapies are the most effective and may help to avoid the occurrence of major adverse events, as well as decrease the costs of treatment.

Comparison of Antihypertensive Drug Classes for Dementia Prevention

New evidence is provided about the potential effects of antihypertensives on risk of dementia through the novel application of instrumental variable analysis and it is shown that the magnitude of the differences between drug classes is smaller than many observational studies have previously reported.